Clinical Updates💉 ⇒ $Larimar Therapeutics (LRMR.US)$ 🟢 ‣ F...

Clinical Updates💉
⇒ $Larimar Therapeutics(LRMR.US)$ 🟢
‣ FDA removes partial clinical hold
‣ Nomlabofusp (CTI-1601) #FA
‣ Protein replacement therapy
‣ Interim data from OLE in Q4 '24 🔔

Clinical readouts 📢
⇒ $Citius Pharmaceuticals(CTXR.US)$ 🟢
‣ Positive Ph3 topline results
‣ Mino-Lok® #CLABSI #CRBSI
‣ Antibiotic lock solution
‣ Overall treatment success in 57.1% patients

Regulatory Update🎯
⇒ $Halozyme Therapeutics(HALO.US)$ $Bristol-Myers Squibb(BMY.US)$
‣ FDA Reassigned PDUFA data to 12/29/24
‣ Subcutaneous Nivolumab Co-Formulated
w/ENHANZE